Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
EBIT Growth

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EBIT Growth(%) -13.1262.53181.36365.47-83.62

What is the latest EBIT Growth ratio of INDOCO REMEDIES ?

The latest EBIT Growth ratio of INDOCO REMEDIES is -13.12 based on Mar2023 Consolidated results.
Year EBIT Growth
Mar2023-13.12
Mar202262.53
Mar2021181.36
Mar2020365.47
Mar2019-83.62

How is EBIT Growth of INDOCO REMEDIES Trending?

Years EBIT Growth % Change
Mar2023 -13.12
Negative
Mar2022 62.53
-65.52
Mar2021 181.36
-50.38
Mar2020 365.47
Positive
Mar2019 -83.62 -

Other Financial Ratios of INDOCO REMEDIES


Compare EBIT Growth ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹3,110.8 Cr 2.7% -0.6% 2.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

2.7%

-0.6%

2.7%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses